Specific VDAC inhibitors: phosphorothioate oligonucleotides

被引:0
|
作者
C.A. Stein
Marco Colombini
机构
[1] Montefiore Medical Center,Albert Einstein–Montefiore Cancer Center, Department of Oncology
[2] University of Maryland,Department of Biology
关键词
Mitochondria; Outer membrane; Blocker; G3139; Randomer;
D O I
暂无
中图分类号
学科分类号
摘要
VDAC channels are ancient, highly-conserved voltage-gated channels in the mitochondrial outer membrane. They are the pathways by which metabolites travel between the cytosol and mitochondria. They are involved in the apoptotic process and probably other functions as well. The lack of specific inhibitors has hampered research in the past but now phosphothioate oligonucleotides can serve this function. These molecules were generated to be stable in the cytosol of cells but, unlike the oligonucleotides with the physiological phosphodiester linkage, these have the ability to bind to and block VDAC channels. They are potent, specific, and available commercially. At 1 μM concentration they block VDAC channels in mitochondria but do not affect the respiration complexes, the adenine nucleotide translocator or the ATP synthase.
引用
收藏
页码:157 / 162
页数:5
相关论文
共 50 条
  • [21] PHOSPHOROTHIOATE OLIGONUCLEOTIDES ARE INHIBITORS OF HUMAN DNA-POLYMERASES AND RNASE H - IMPLICATIONS FOR ANTISENSE TECHNOLOGY
    GAO, WY
    HAN, FS
    STORM, C
    EGAN, W
    CHENG, YC
    MOLECULAR PHARMACOLOGY, 1992, 41 (02) : 223 - 229
  • [22] INVIVO STUDIES WITH PHOSPHOROTHIOATE OLIGONUCLEOTIDES - PHARMACOKINETICS PROLOGUE
    IVERSEN, P
    ANTI-CANCER DRUG DESIGN, 1991, 6 (06): : 531 - 538
  • [23] IN-VITRO PHARMACOKINETICS OF PHOSPHOROTHIOATE ANTISENSE OLIGONUCLEOTIDES
    CROOKE, RM
    GRAHAM, MJ
    COOKE, ME
    CROOKE, ST
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 275 (01): : 462 - 473
  • [24] Identification of PKCα isoform-specific effects in cardiac myocytes using antisense phosphorothioate oligonucleotides
    Kerkelä, R
    Ilves, M
    Pikkarainen, S
    Tokola, H
    Ronkainen, J
    Vuolteenaho, O
    Leppäluoto, J
    Ruskoaho, H
    MOLECULAR PHARMACOLOGY, 2002, 62 (06) : 1482 - 1491
  • [25] Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides
    Kocisko, DA
    Vaillant, A
    Lee, KS
    Arnold, KM
    Bertholet, N
    Race, RE
    Olsen, EA
    Juteau, JM
    Caughey, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) : 1034 - 1044
  • [26] Conjugation Reactions Involving Maleimides and Phosphorothioate Oligonucleotides
    Sanchez, Albert
    Pedroso, Enrique
    Grandas, Anna
    BIOCONJUGATE CHEMISTRY, 2012, 23 (02) : 300 - 307
  • [27] Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides
    Mannon, RB
    Nataraj, C
    Pisetsky, DS
    CELLULAR IMMUNOLOGY, 2000, 201 (01) : 14 - 21
  • [28] Phosphorothioate oligonucleotides as aptamers of retroviral reverse transcriptases
    Koziolkiewicz, M
    Krakowiak, A
    Owczarek, A
    Boczkowska, M
    RNA BIOCHEMISTRY AND BIOTECHNOLOGY, 1999, 70 : 315 - 324
  • [29] Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex
    Sheehan, JP
    Lan, HC
    BLOOD, 1998, 92 (05) : 1617 - 1625
  • [30] Inhibition of platelet heparitinase by phosphorothioate DNA oligonucleotides
    Graham, LD
    Mitchell, SM
    Underwood, PA
    BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, 1995, 37 (02): : 239 - 246